Replies to post #69410 on Amarin Corp Plc (AMRN)

[rafunrafun]

Great stuff, thanks for posting. I'm curious when those discussions took place - would have loved hear their thoughts on why ANCHOR wasn't approved.

It's nice to be reassured by professionals about what has been posted here about EPA.

[couldbebetter]

Wow! Very much worth listening to. Thanks for posting.

[marzan]

GG, how old is this webinar? what an amazing panel! A wealth of info on TG lowering including non HDL comparison and inflammation reduction as opposed to niacin and fibrates by V and on safety risks taking DS etc etc.

BB, have u sent this link to Woodcock? she must know this or perhaps aware of these already but still wants convincing data from the one and only unique Rit.

No matter what, in the process Woodcock is doing a huge favor to Amarin with all these roadblocks in that take us to RIt. Otherwise we would have been sold out by now. I'm sure we are all goin to be filthy rich once Rit is out. Thank you Janet!

[sts66]

Nice, but the very first sentence sort of negates the contents of the article, at least from the general public's POV - link to transcript:

http://nlaresourcecenter.lipidjournal.com/Content/PDFs/Transcript-2015.pdf

This article is supported by a grant from Amarin Pharma, Inc.

Two of the 5 docs are also paid researchers for AMRN. Look at it another way - if the article were about the benefits of statins and the LDL-C CV risk theory, would you believe a word of it?

[Whalatane]

GG excellent find

Thx for the link

Kiwi

[Biobillionair]

I really like this R-I writeup: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open- label, blinded endpoint analysis
http://nlaresourcecenter.lipidjournal.com/Content/PDFs/Yokoyama-Effects.pdf

BB